Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NeoType Biosciences is a German precision oncology company specializing in advanced diagnostic services and biomarker discovery for the pharmaceutical and biotechnology industries. The company provides a comprehensive suite of high-complexity testing, including liquid biopsy, next-generation sequencing (NGS), and multiplex immunofluorescence, to support clinical trial stratification and drug development. Founded by experts in molecular diagnostics, NeoType focuses on delivering integrated multi-omic insights to enable personalized cancer treatment. They operate as a specialized Contract Research Organization (CRO) with a focus on complex biomarker assays and data-driven oncology solutions. The company aims to accelerate the clinical adoption of novel biomarkers by providing high-quality, scalable diagnostic platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Neotype Biosciences.